AI-Powered Protein Engineering

Engineering the Perfect Conformation with AI & Advanced Algorithms

ConformaBio is the first company to pioneer conformation-based biotherapeutic design — combining artificial intelligence with proprietary computational algorithms to control and optimize protein conformations from the ground up. We maximize efficacy, stability, and manufacturability of next-generation vaccines and therapeutic proteins.

By generating ConformaX — our optimized conformational variants — we are unlocking a potential new frontier in synthetic biology, where protein structure is designed with intent, not left to chance.

Partner With Us → Explore Our Services

The Problem

Conformation isn't a side effect.
It's the design parameter.

Even minor shifts in a protein's three-dimensional structure can dramatically alter its stability, immunogenicity, and biological activity. Yet traditional development treats conformation as a secondary outcome — something observed, not engineered.

We take the opposite approach. Our AI-driven algorithms target critical structural regions — hinge domains, linkers, and flexible loops — to lock proteins into their most effective shape from day one. The result: higher potency, longer shelf-life, and fewer surprises in the clinic.

Instability Risk: Protein instability and aggregation represent a primary risk to biologic efficacy throughout manufacturing, storage, and clinical use.

AI-Enhanced Stability: AI-designed protein variants have demonstrated thermal stability increases of 20-50 degrees C above wild-type baselines in prospective studies.

Cold-Chain Burden: The global cold-chain logistics market for biologics was valued at over $18 billion in 2024, projected to reach $44 billion by 2033.

Our Services

End-to-end AI-powered services
for biologics development

From computational design to analytical validation — we cover the full spectrum of biotherapeutic engineering.

Design Your Biotherapeutic

Our AI-powered platform lets you design therapeutic proteins and vaccine candidates from sequence to structure — with conformation engineered in from the start, not optimized after the fact.

AI-guided sequence design optimized for target conformation
Hinge and linker engineering for multi-domain constructs
Stability and aggregation prediction before wet-lab synthesis
Customized constructs for improved pharmacokinetics and efficacy
Iterative design cycles powered by machine learning feedback loops

Bioanalytical Assessment

We don't operate a wet lab — instead, we bring deep bioanalytical expertise to help you evaluate and troubleshoot your data. Think of us as your specialized consultant for bioanalytical assessment, similar to how SFDA consultants support regulatory submissions.

Expert review and assessment of bioanalytical data packages
Evaluation of method validation reports and study designs
Identification of issues in stability, potency, and characterization data
Guidance on regulatory-aligned bioanalytical strategies
Consulting support for CMC and quality-related bioanalytical questions

AI Engine — Conformation-Aware Protein Design

At the core of our platform is a proprietary AI and algorithmic engine built from the ground up to predict, control, and optimize protein conformation — combining deep learning, structural bioinformatics, and physics-based simulation.

AI-Powered Structural Bioinformatics

Deep learning models map the full conformational landscape using vast structural databases and learned sequence-structure relationships.

Dynamics-Based Simulation

Physics-informed algorithms simulate molecular motion to identify flexible regions, hinge behaviors, and conformational transition pathways.

ML-Enhanced Energy Scoring

Machine learning models score and rank candidate conformations by thermodynamic stability, binding affinity, and functional fitness.

Predictive Conformation Engineering

Our algorithms forecast how sequence and structural changes will impact conformation, stability, and downstream biological function — before synthesis.

Platform Capabilities

AI-driven conformation engineering
for vaccines and therapeutic proteins

Our algorithms guide and optimize the 3D conformation of biologics — locking them into their most potent, stable form before they ever reach the bench.

Wild-type vs designed conformer comparison - red and blue protein structures

Wild-Type (red) vs. Designed Conformer (blue)

Hinge Region Identification & Engineering

Identify and engineer critical hinge regions to gain precise control over protein conformation. By targeting these flexible structural switches — the linkers and loops connecting functional domains — we dictate how the protein folds, moves, and presents itself to biological targets.

Better Immunogenic Response

Elicit stronger, more effective immune responses by exposing both cryptic and surface-accessible epitopes essential for recognition. Our conformation-aware design ensures optimal antigen presentation — unlocking better immunogenic profiles for next-generation vaccines and biologics.

Stability Enhancement

Improve overall protein stability through conformation-guided engineering — reducing aggregation, increasing half-life, and introducing optimal mutations that enhance thermostability, shelf-life, and in-vivo durability.

Manufacture-Ready Designs

AI-optimized constructs ready for scalable production — reducing development timelines and manufacturing costs from the start.

Results & Validation

Data validating our
conformation engineering approach

Our algorithm has been tested against real protein targets — here are the results that demonstrate its effectiveness.

Hinge Identification

Validated Hinge Region Detection Across Multiple Protein Targets

Our algorithm accurately identifies known hinge regions in both the SARS-CoV-2 spike protein (top, ~3,400 residues) and Cadherin (bottom, ~145 residues). Arrows indicate predicted hinge positions; green stars mark validated potential regions — demonstrating reliability across proteins of vastly different sizes and structural complexity.

Wild-Type (WT) — RMSD ~2.5-3.5 A

Designed Conformer — RMSD ~1.5-2.0 A

Stability

Stable Designed Conformer in Comparison to Wild-Type Protein

Molecular dynamics simulations (100 ns) comparing the wild-type protein (top) against our designed conformer (bottom). The engineered variant shows significantly reduced RMSD fluctuation and tighter conformational stability, with PCA analysis (insets) confirming a more compact conformational sampling space.

Structural Analysis

Analyze the 3D structure of the target protein or vaccine candidate

Molecular Dynamics Evaluation

Simulate and evaluate conformational behavior over time

Hinge Detection Algorithm

Apply our proprietary algorithm to identify critical hinge regions

Modification Strategy

Engineer targeted modifications for optimized conformation and stability

Workflow

Algorithm Pipeline Overview

From structural analysis through molecular dynamics evaluation, hinge detection, and targeted modification — our end-to-end pipeline delivers conformation-optimized protein designs.

Why It Matters

A new standard for protein-based medicine

AI-engineered conformations mean better outcomes — from the lab bench to the patient.

Longer-Lasting Biologics

More robust vaccines and therapeutics that maintain potency across storage, transport, and diverse clinical settings.

Lower Development Risk

AI-validated designs mean higher success rates from preclinical through clinical — with fewer late-stage failures due to stability or formulation issues.

Faster Path to Market

Algorithmically streamlined development and reduced cold-chain dependence — enabling broader, faster access especially in underserved regions.

Engineering the Perfect Conformation with AI & Advanced Algorithms

Conformation isn't a side effect.
It's the design parameter.